Lupin gets USFDA nod for diabetes drug tablets, boosting presence in key US market
Drugmaker Lupin Ltd on Wednesday, April 8, said it has received approval from the US Food and Drug Administration for its Dapagliflozin and Metformin Hydrochloride extended-release tablets in multiple strengths in the United States. The approval covers tablets in 5 mg/500 mg, 5 mg/1,000 mg, 10 mg/500 mg and 10 mg/1,000 mg strengths, while a…
